Research Topics
| Richard L AttanoosSummaryAffiliation: University Hospital of Wales Country: UK Publications
| Collaborators
|
Detail Information
Publications
An approach to industrial post mortemsRichard L Attanoos
Department of Histopathology, University Hospital Llandough, Cardiff and Vale NHS Trust, Penarth, Wales, UK
Histopathology 54:134-42. 2009..This review addresses the complex issues of ascribing disease to industrial exposures and the role of mineral analysis. The authors discuss the common medical legal issues that are encountered at post mortem and at inquest deposition...
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesotheliomaR L Attanoos
Department of Histopathology, Cardiff and Vale NHS Trust, Llandough Hospital, Cardiff, UK
Histopathology 53:340-4. 2008..To evaluate the diagnostic accuracy of closed and open pleural biopsies in diagnosing malignant pleural mesothelioma...
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2R L Attanoos
Department of Histopathology, Llandough Hospital, Cardiff and Vale NHS Trust, Penarth, Cardiff, Wales, UK
Histopathology 43:231-8. 2003....
'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, CardiffR L Attanoos
Department of Histopathology, Llandough Hospital, Cardiff, UK
Histopathology 43:444-52. 2003..To undertake a clinicopathological study of diffuse serosal neoplasms of epithelial histogenesis which clinically and pathologically mimic malignant pleural mesothelioma...
Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individualsR L Attanoos
Department of Histopathology, Llandough Hospital, Cardiff and Vale NHS Trust, Cardiff, Wales, UK
Histopathology 43:387-92. 2003..The development of synchronous diffuse malignant mesothelioma and carcinoma in individuals exposed to asbestos is rare. We report nine cases and discuss the medico-legal implications...
The clinical impact of expert pathological review on lymphoma management: a regional experienceJason F Lester
Velindre Hospital NHS Trust, Cardiff, UK
Br J Haematol 123:463-8. 2003..Overall, management was changed in 8% of cases referred for central pathological review. In conclusion, expert central pathological review has a direct effect on patient management...
Nodular glomeruloid pleuroblastoma: a biphasic pleural-based malignant tumor with immature elementsPinias Mukonoweshuro
Department of Histopathology, Derriford Hospital, Plymouth, UK
Virchows Arch 449:253-7. 2006..The diagnostic problems and medicolegal issues surrounding the diagnosis and differentiation from malignant pleural mesothelioma and other tumors are discussed...
Coexistent atypical adenomatous hyperplasia, primary lung adenocarcinoma and pleural mesothelioma in an asbestos-exposed subjectD H Thomas
Histopathology 45:540-2. 2004
The pathology associated with therapeutic procedures in malignant mesotheliomaR L Attanoos
Department of Histopathology, Cardiff and Vale NHS Trust, Llandough Hospital, Cardiff, UK
Histopathology 45:393-7. 2004..In the 12 decortication specimens and two pleuropneumonectomy resections, post mortem examination identified evidence of residual malignant mesothelioma of similar morphological subtype and immunophenotype to the resected tumour...
Unusual contaminant fibres on mineral analysisR L Attanoos
Histopathology 43:405-6. 2003
Sister Mary Joseph's nodule in malignant peritoneal mesotheliomaA M Boyde
Histopathology 43:303-4. 2003
Unusual intraparenchymal growth patterns of malignant pleural mesotheliomaN R Nind
Department of Histopathology, Llandough Hospital, Cardiff and Vale NHS Trust, Cardiff, UK
Histopathology 42:150-5. 2003....
Primary thymic epithelial tumours of the pleura mimicking malignant mesotheliomaR L Attanoos
Department of Histopathology, Llandough Hospital, and Vale NHS Trust, Cardiff, UK
Histopathology 41:42-9. 2002..In contrast, nuclear calretinin expression favours malignant mesothelioma...
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneumR L Attanoos
Department of Histopathology, Llandough Hospital, Cardiff and Vale NHS Trust, Penarth, Vale of Glamoran, UK
Histopathology 40:237-44. 2002..The other mesothelial markers (thrombomodulin, cytokeratin 5/6, and CD44H) and carcinoma markers (polyclonal and monoclonal CEA, and Leu-M1) yielded a too low sensitivity for practical use...
Malignant mesothelioma: morphological variantsR L Attanoos
Llandough Hospital, Cardiff, Wales, U.K
Pathologica 95:302-3. 2003
Mediastinal mixed dendritic cell sarcoma with hybrid featuresK M Dillon
Department of Pathology, Royal Group of Hospitals Trust, Belfast BT12 6BL, Northern Ireland
J Clin Pathol 55:791-4. 2002..Immunohistochemistry and/or electron microscopy are required for a definitive diagnosis. This case shows that hybrid neoplasms can occur, which have features of both follicular and interdigitating dendritic cells...
Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological patternR L Attanoos
Department of Histopathology, Llandough Hospital, Cardiff and Vale NHS Trust, Penarth, Wales, UK
Histopathology 39:584-8. 2001..Accurate interpretation of immunohistochemistry in mesothelioma requires an awareness of the immunophenotypic heterogeneity identified in different histological forms of the tumour, and this is of particular importance in small biopsies...
